Beyond HumanBig PictureCatalystsConnected WorldExchangeMarketing MixNew MoneyNew SchoolPeople SciencePulse

How Philips is setting the standard for innovation in pharmaceuticals using big data

Roy Smythe

After 15 years of collating patient data, Philips is at the forefront of clinical trial innovation as it uses this information to inform more effective treatments.

Today, around 60 percent of Philips’ funding is spent on software, with a large proportion of that focused on big data and AI projects. We spoke to Roy Smythe, Philips’ Chief Medical Officer, Strategy and Partnerships, at the time of filming, about how this has been integral to its innovative research; research that features companion diagnostic work using patient’s physiological data to model clinical trials.

This interview is part of ‘The Age of Transformation: How Pharma can Harness the Power of Data’, a series powered by Medidata.